![Jennifer Davis](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 793 154 $ al 31/05/2026
Jennifer L.
Davis is an Independent Director at AbbVie, Inc. since 2023.
Ms. Davis was Chief Executive Officer-Health Care at Procter & Gamble Co. from 2022 to 2026.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
ABBVIE, INC. 0 % | 08/05/2026 | 3.643 ( 0 % ) | 793 154 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| ABBVIE INC. | Director/Miembro de la Junta | 11/10/2023 |
| Empresas | Cargo | Fin |
|---|---|---|
| PROCTER & GAMBLE COMPANY | Corporate Officer/Principal | 01/04/2026 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 2 |
|---|---|
Procter & Gamble Co.
 Procter & Gamble Co. Household/Personal CareConsumer Non-Durables Manufactures and sells fabric & home care products, diapers, baby wipes, tissues, toilet paper, hair, skin and personal care, toothbrushes, vitamins, supplements & razors | Consumer Non-Durables |
AbbVie, Inc.
 AbbVie, Inc. Pharmaceuticals: MajorHealth Technology Engages in the research and development, manufacturing, commercialization & sale of immunology medicines and therapies | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
